Eli Lilly's dominance in the GLP-1 market and strong revenue growth forecast make LLY stock a promising investment, with a ...

The round is one of Europe’s largest-ever biotech VC deals, signalling investor appetite for the booming weight loss market.

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 494.50% and ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

January 10 has been named ‘Quitters Day’ because it is the day in which most people have given up on their new year’s ...

In today’s health headlines, the HMPV virus and what you need to know. Plus, wildfire smoke and air quality, and is iodine ...